01261nas a2200325   4500000000100000008004100001260001300042653001000055653001500065653001200080653002800092653002200120653001100142653002000153653001100173653002300184653002400207653002500231653002500256653001700281653001300298100001000311700001800321700001400339245004500353300000900398490000700407520050700414022001400921       2011                            d  c2011 Jan10aAdult10aCellulitis10aDapsone10aDiagnosis, Differential10aFacial Dermatoses10aFemale10aGlucocorticoids10aHumans10aLeprostatic Agents10aLeprosy, Borderline10aLeprosy, Tuberculoid10aMycobacterium leprae10aPrednisolone10aRifampin1 aAli K1 aSittampalam G1 aMalik M A00aFacial tuberculoid leprosy: case report.  a70-20 v493 a<p>Leprosy is a chronic, infectious, systemic disease caused by Mycobacterium leprae and is classified as paucibacillary and multibacillary types. It is contagious and has an insidious onset. Clinical presentation is characterised by hypopigmented skin lesions with reduced sensation. Presence of acid-fast bacilli in tissue specimens is regarded as a gold standard for diagnosis. Treatment is based on multi-drug regimens. We report a case of borderline tuberculoid leprosy in a 31-year-old woman.</p>  a1532-1940